Mattsson, Elisabet
Ljungman, Lisa
Einhorn, Kim
Sundström Poromaa, Inger
Stålberg, Karin
Wikman, Anna http://orcid.org/0000-0003-0937-0887
Funding for this research was provided by:
Uppsala University
Article History
Received: 20 May 2020
Accepted: 22 November 2020
First Online: 22 December 2020
Ethics approval and consent to participate
: Ethical approval to conduct the study was granted by the Regional Ethical Review Board in Uppsala, Sweden (Reference number: 2016/221). Ethical approval comprised the procedure to collect informed consent, i.e., participants gave their written consent to participate by responding to the survey. Respondents were informed that by responding and returning the paper version of the survey or by answering the online version of the survey they consented to participate in the study. The date of response (paper/online) was recorded with the study code to document consent.
: Not applicable.
: Over the past five years, ISP has served occasionally on advisory boards or acted as invited speaker at scientific meetings for MSD, Bayer Health Care, Gedeon Richter, Peptonics, Shire/Takeda, and Lundbeck A/S. All other authors declare that they have no conflicts of interest.